iScience Interventional
Menlo Park
About iScience Interventional
iScience Interventional™ discovers and develops microcatheter and imaging technologies that enable ophthalmologists to deliver site-specific ocular therapies. This new category of therapy is called Interventional Ophthalmology. It encompasses microcatheter-based therapies designed to access a wide range of anatomical structures within the eye to aspirate ocular fluids or deliver sterile ophthalmic solutions to the eye.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $83.7M
- Last round: Debt Financing (May 2012)
- Website: iscienceinterventional.com
- Phone: +1 650 421 2700
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Canonical: https://fsome.com/organization/iscience-interventional-1318370 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.